Primary Job Title Founder Primary Organization Cx Precision Medicine
Gender Male
Dr. O’Bryant is a founding member of the CxPM Precision Medicine development team and is one of the world’s leading experts in blood-based biomarkers of Alzheimer’s and other neurodegenerative diseases.
He is the Executive Director at the Institute for Translational Research and the Dr. Joe and Peggy Schooler Endowed Chair in Pharmacology and
Neurscience at the University of North Texas Health Science Center. Dr. O’Bryant leads multiple initiatives focused on precision medicine approaches to diagnosing and treating neurodegenerative diseases including Alzheimer’s Disease, Parkinson’s Disease, Lewy Bodies Dementia and Alzheimer’s Disease among adults with Down Syndrome.
